Full View

Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy

TF Overvad, AG Ording, PB Nielsen, F Skjøth… - Blood …, 2022 - ashpublications.org
The Khorana score is recommended for guiding primary venous thromboembolism (VTE)
prophylaxis in cancer patients, but its clinical utility overall and across cancer types remains …
被引用次数：34 相关文章
[HTML] sciencedirect.com

[HTML][HTML] Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy

TF Overvad, AG Ording, PB Nielsen, F Skjøth… - Blood Advances, 2022 - Elsevier
The Khorana score is recommended for guiding primary venous thromboembolism (VTE)
prophylaxis in cancer patients, but its clinical utility overall and across cancer types remains …
[HTML] nih.gov

[HTML][HTML] Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy

TF Overvad, AG Ording, PB Nielsen, F Skjøth… - Blood …, 2022 - ncbi.nlm.nih.gov
The Khorana score is recommended for guiding primary venous thromboembolism (VTE)
prophylaxis in cancer patients, but its clinical utility overall and across cancer types remains …

Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy

TF Overvad, AG Ording, PB Nielsen, F Skjøth… - Blood Advances, 2022 - pure.au.dk
The Khorana score is recommended for guiding primary venous thromboembolism (VTE)
prophylaxis in cancer patients, but its clinical utility overall and across cancer types remains …

Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy.

TF Overvad, AG Ording, PB Nielsen, F Skjøth… - Blood …, 2022 - europepmc.org
The Khorana score is recommended for guiding primary venous thromboembolism (VTE)
prophylaxis in cancer patients, but its clinical utility overall and across cancer types remains …

Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy

TF Overvad, AG Ording, PB Nielsen, F Skjøth… - Blood advances, 2022 - vbn.aau.dk
The Khorana score is recommended for guiding primary venous thromboembolism (VTE)
prophylaxis in cancer patients, but its clinical utility overall and across cancer types remains …
[PDF] core.ac.uk

[PDF][PDF] Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy

TF Overvad, AG Ording, PB Nielsen, F Skjøth… - 2022 - core.ac.uk
Cancer incidence is rising, and venous thromboembolism (VTE) remains a common and
potentially fatal complication among patients with cancer. 1, 2 Cancer-associated VTE poses …

Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy

TF Overvad, AG Ording, PB Nielsen… - Blood …, 2022 - pubmed.ncbi.nlm.nih.gov
The Khorana score is recommended for guiding primary venous thromboembolism (VTE)
prophylaxis in cancer patients, but its clinical utility overall and across cancer types remains …

Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy

TF Overvad, AG Ording, PB Nielsen… - Blood …, 2022 - pubmed.ncbi.nlm.nih.gov
The Khorana score is recommended for guiding primary venous thromboembolism (VTE)
prophylaxis in cancer patients, but its clinical utility overall and across cancer types remains …
[PDF] aau.dk

[PDF][PDF] Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy

TF Overvad, AG Ording, PB Nielsen, F Skjøth… - 2022 - vbn.aau.dk
Cancer incidence is rising, and venous thromboembolism (VTE) remains a common and
potentially fatal complication among patients with cancer. 1, 2 Cancer-associated VTE poses …